SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-09-020492
Filing Date
2009-07-07
Accepted
2009-07-07 14:55:08
Documents
6
Period of Report
2009-07-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 OXIGENE, INC. b76150oie8vk.htm 8-K 20042
2 EX-10.1 AMENDED AND RESTATED PURCHASE OPTION AGREEMENT b76150oiexv10w1.htm EX-10.1 167769
3 EX-10.2 AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT b76150oiexv10w2.htm EX-10.2 117983
4 EX-10.3 TERMINATION AGREEMENT b76150oiexv10w3.htm EX-10.3 19287
5 EX-99.1 PRESS RELEASE DATED JULY 6, 2009 b76150oiexv99w1.htm EX-99.1 13598
6 GRAPHIC b76150oib7615000.gif GRAPHIC 2991
  Complete submission text file 0000950123-09-020492.txt   344535
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21990 | Film No.: 09933188
SIC: 2836 Biological Products, (No Diagnostic Substances)